Tuesday, June 27, 2023

Global Health Policy Update: Tackling Antimicrobial Resistance & Investing in Pandemic Preparedness







CGD Update:




Global Health Policy: Tackling Antimicrobial Resistance & Investing in Pandemic Preparedness


Hi Charles,

Without concerted action, it is estimated that antimicrobial resistance (AMR) will kill 10 million people globally by 2050. CGD’s global health policy team recently outlined key policy solutions to address the threat of AMR in India and Brazil. And on the sidelines of the World Health Assembly in Geneva last month, CGD experts presented two draft global recommendations to tackle AMR on both the political and operational fronts. Stay tuned for CGD’s final working group report on AMR, which will be launched at the United Nations General Assembly in September this year.  

Building on CGD’s extensive commentary informing the Pandemic Fund’s establishment and operationalization, a new CGD brief looks at how the newly-created Fund can strategically invest in pandemic preparedness, including during its first call for proposals for surveillance, laboratories, and human resources. 

Lastly, we take a look at CGD’s role in improving value for money of healthcare through Health Technology Assessment India (HTAIn), which has achieved a return on investment of 9:1 since its establishment in 2017. 

For more on health economics, CGD is participating in several events at IHEA’s 2023 Congress next month, including a roundtable on tracking and measuring spending for pandemic preparedness and response. To register or for more details, see CGD’s website

Please read on for more on our latest research and commentary. As always, your thoughts, feedback, and suggestions are welcome. 


Javier Guzman 
Director, Global Health Policy Program and Senior Policy Fellow 


Explore CGD’s Global Health Work






Towards the 2024 UNGA Meeting on Antimicrobial Resistance


Turning the Tide on AMR through Global Cooperation 


CGD’s working group on AMR is developing two key recommendations to tackle the threat of AMR. First, a ‘Grand Bargain’ outlines principles and commitments for key stakeholders in the global antimicrobial market. Second, the establishment of a new global procurement hub for antimicrobials would support core functions, such as purchasing, distribution, and providing technical and financial assistance. 


Read the blog



Tackling the Threat of AMR in India and Brazil 


Every year, 300,000 and 33,000 people die of drug resistant infections in India and Brazil, respectively. CGD has partnered with the Indian School of Business and INCAE Business School to identify a number of policy options to tackle AMR. Although India and Brazil face similar challenges in terms of antimicrobial access, innovation, and stewardship, politically palatable solutions vary substantially—but if implemented, both countries have the potential to become regional leaders in the fight against AMR.


Read the blog






Investing in Surveillance for Pandemic Preparedness and Response


A new policy paper from CGD examines how analyzing the “best buys” of outbreak surveillance interventions—reflecting potential costs and benefits—can bolster pandemic preparedness efforts. Analysis suggests that the payoffs and trade-offs of investments are not easily assessed before a pandemic, highlighting the need for more rigorous, independent evaluation of the value and impact of preparedness investments (including for surveillance) after the fact to inform future pandemic response investments. 


Read the blog



More on PPR










Ending the Scourge of Lead Poisoning



1 in 3 children suffer from lead poisoning—it causes irreversible brain damage, and is linked to poor schooling outcomes, increased crime and violence, and heart and kidney damage. Yet lead pollution has been sorely neglected by the international community. A half-day event at CGD brought together experts to discuss high-impact strategies to create a future free of lead poisoning—in America and around the world. 


Watch the event






Featured Policy Impact 


Supporting the Institutionalization of Health Technology Assessment in India


Through the International Decision Support Initiative (iDSI), CGD has supported the use of cost-effectiveness analysis to improve the impact of health spending decisions in India. With iDSI support, HTAIn—the Indian HTA agency established in 2017—has grown into a network with 18 Regional Resource Centres across India and has achieved fundamental milestones, including formalizing processes and procedures and implementing a National Health System Cost database. 

HTAIn has published more than 40 policy briefs assessing a diverse set of interventions ranging from public health initiatives (e.g., cervical cancer screening) to diagnostic tests. It has already shown its value—after assessing the benefits from three HTAs, we estimate that for every rupee spent on HTAIn to support priority setting, India has secured the equivalent of nine rupees in health system performance.
India’s continued commitment to HTA was recently reaffirmed at the second International Symposium on Health Technology Assessment organized by HTAIn, CGD, and WHO in March 2023 and attended by the Honourable Vice President of India Shri Jagdeep Dhankhar. In the words of Union Minister of Health and Family Welfare Dr Mandaviya, “HTA is an important mechanism for priority setting in the country to achieve our goal of providing equitable, better quality health care services in a cost-effective way.” 

CGD will continue to support India, including through HTAIn, to promote value for money and improved health outcomes.






In Case You Missed It 






Research and Analysis







Follow Us on Twitter


Follow our experts on Twitter to keep up with the latest news and research on global health policy: 

Javier Guzman, Director, Global Health Policy Program and Senior Policy Fellow – @JavierHGuzmanC 
Janeen Madan Keller, Policy Fellow and Deputy Director - @JaneenMadan
Peter Baker, Policy Fellow and Deputy Director – @peterbaker17 
Prashant Yadav, Senior Fellow – @Prof_Yadav_SCM
Rachel Silverman, Senior Fellow – @rsilv_dc 
Anthony McDonnell, Senior Policy Analyst – @apmcdonnell 
Srobana Ghosh, Policy Analyst – @srobanaghosh 

And keep up with some of our non-resident fellows too: 

Sebastian Bauhoff – @sbauhoff
Ursula Giedion – @ugiedion
Adriane Gheorghe – @adrianegheorghe









This email was sent to bema@blackemergmanagersassociation.org.
This email was sent by:
Center for Global Development
2055 L Street NW, Fifth Floor
Washington, DC 20036
Tel 202.416.4000 | Fax 202.416.4050




Manage Subscriptions  |  Unsubscribe  |  About  |  Donate  |  Contact



No comments:

Post a Comment


Search This Blog

ARCHIVE List 2011 - Present